Cargando…

COVID-19 mRNA vaccines: acute allergic reaction and anaphylaxis

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978451/
http://dx.doi.org/10.1007/s40278-021-92563-3
_version_ 1783667212893028352
collection PubMed
description
format Online
Article
Text
id pubmed-7978451
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-79784512021-03-23 COVID-19 mRNA vaccines: acute allergic reaction and anaphylaxis Reactions Weekly Clinical Study Springer International Publishing 2021-03-20 2021 /pmc/articles/PMC7978451/ http://dx.doi.org/10.1007/s40278-021-92563-3 Text en © Springer International Publishing AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Clinical Study
COVID-19 mRNA vaccines: acute allergic reaction and anaphylaxis
title COVID-19 mRNA vaccines: acute allergic reaction and anaphylaxis
title_full COVID-19 mRNA vaccines: acute allergic reaction and anaphylaxis
title_fullStr COVID-19 mRNA vaccines: acute allergic reaction and anaphylaxis
title_full_unstemmed COVID-19 mRNA vaccines: acute allergic reaction and anaphylaxis
title_short COVID-19 mRNA vaccines: acute allergic reaction and anaphylaxis
title_sort covid-19 mrna vaccines: acute allergic reaction and anaphylaxis
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978451/
http://dx.doi.org/10.1007/s40278-021-92563-3